Which companies are on the cutting edge of prostate cancer research?
Cancer Research Technology (CRT) is an oncology-focused development and commercialisation company that realises cancer patient benefit from publicly-funded research worldwide. At CRT we bridge the fundamental gap between cutting edge academic research and industrial development of cancer therapeutics and diagnostics. We achieve this by working closely with prestigious international research institutes and funding bodies to develop, protect and commercialise oncology related discoveries. Core activities of business development and drug discovery are supported by specialist, integrated teams of patent, legal, finance and marketing personnel. Our exclusive focus in oncology provides for an unrivalled depth of knowledge and experience in cancer-specific translational development and commercialisation. CRT is wholly owned by the charity Cancer Research UK, the largest independent funder of cancer research in the world. All proceeds are shared with inventors and their institutions, whilst pr
